de Ferranti S D, Ioannidis J P, Lau J, Anninger W V, Barza M
Division of Clinical Care Research, Department of Medicine, New England Medical Center, 750 Washington Street, Boston, MA 02111, USA.
BMJ. 1998 Sep 5;317(7159):632-7. doi: 10.1136/bmj.317.7159.632.
To examine whether antibiotics are indicated in treating uncomplicated acute sinusitis and, if so, whether newer and more expensive antibiotics with broad spectra of antimicrobial activity are more effective than amoxycillin or folate inhibitors.
Meta-analysis of randomised trials.
Outpatient clinics.
2717 patients with acute sinusitis or acute exacerbation of chronic sinusitis from 27 trials.
Any antibiotic versus placebo; amoxycillin or folate inhibitors versus newer, more expensive antibiotics.
Clinical failures and cures.
Compared with placebo, antibiotics decreased the incidence of clinical failures by half (risk ratio 0.54 (95% confidence interval 0.37 to 0.79)). Risk of clinical failure among 1553 randomised patients was not meaningfully decreased with more expensive antibiotics as compared with amoxycillin (risk ratio 0.86 (0.62 to 1.19); risk difference 0.9 fewer failures per 100 patients (1.4 more failures to 3.1 fewer failures per 100 patients)). The results were similar for other antibiotics versus folate inhibitors (risk ratio 1.01 (0.52 to 1.97)), but data were sparse (n=410) and of low quality.
Amoxycillin and folate inhibitors are essentially as effective as more expensive antibiotics for the initial treatment of uncomplicated acute sinusitis. Small differences in efficacy may exist, but are unlikely to be clinically important.
探讨抗生素是否适用于治疗非复杂性急性鼻窦炎;若适用,抗菌谱更广的新型且更昂贵的抗生素是否比阿莫西林或叶酸抑制剂更有效。
随机试验的荟萃分析。
门诊诊所。
来自27项试验的2717例急性鼻窦炎或慢性鼻窦炎急性加重患者。
任何抗生素与安慰剂对比;阿莫西林或叶酸抑制剂与新型、更昂贵的抗生素对比。
临床治疗失败和治愈情况。
与安慰剂相比,抗生素使临床治疗失败的发生率降低了一半(风险比0.54(95%置信区间0.37至0.79))。与阿莫西林相比,使用更昂贵的抗生素时,1553例随机分组患者的临床治疗失败风险未显著降低(风险比0.86(0.62至1.19);每100例患者的治疗失败风险差为少0.9例(每100例患者多1.4例失败至少3.1例失败))。其他抗生素与叶酸抑制剂对比的结果相似(风险比1.01(0.52至1.97)),但数据稀少(n = 410)且质量较低。
阿莫西林和叶酸抑制剂在非复杂性急性鼻窦炎的初始治疗中与更昂贵的抗生素基本一样有效。疗效可能存在微小差异,但在临床上不太可能具有重要意义。